
|Articles|June 18, 2007
Latebreakers: Revision made of Actos label
A request from the FDA has led to a revision of the prescribing information for pioglitazone (Actos, Takeda Pharmaceuticals).
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Severe COVID-19 Increases Stroke Risk for Patients With Asthma
2
The Variety of Migraine Treatment Options Opens the Door for Pharmacy Services | NCPA 2025
3
The Rise in Supplement Use Calls for Pharmacist-Led Counseling, Education | NCPA 2025
4
How Community Pharmacists Are Proactively Managing Patients’ Migraines | NCPA 2025
5